ITCI
Intra-Cellular Therapies
Intra-Cellular Therapies is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Company Sector
APIs
6 companies tagged with APIs.
APIs refers to active pharmaceutical ingredients, the core chemical or biologic substances used to make medicines. Companies in this category are typically exposed to manufacturing scale, supply reliability, and the economics of pharmaceutical production rather than a single branded asset story.
IOVA
Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics is a commercial-stage cell therapy company focused on tumor-infiltrating lymphocyte, or TIL, therapies for solid tumors. The company's story is centered on turning a complex personalized treatment approach into a scalable oncology franchise, with investors watching launch execution, adoption, and the broader expansion of the TIL platform.
RPID
Rapid Micro Biosystems
Rapid Micro Biosystems is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
SIOX
Sio Gene Therapies
Sio Gene Therapies is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
SNDX
Syndax Pharmaceuticals
Syndax Pharmaceuticals is an oncology company focused on targeted therapies and hematologic disease opportunities. Investors watch trial readouts, regulatory milestones, and how the company converts its pipeline into commercial traction.
TSHA
Taysha Gene Therapies
Taysha Gene Therapies is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.